Neuroendocrine cancers (NC) are England’s tenth most prevalent cancer. Yet awareness of these cancers is very low, even among healthcare professionals (HCPs). People living with NC experience inequities in diagnosis, disease management and care due to a lack of...
RESEARCH SPOTLIGHT MARCH 2021 – CLINICAL TRIALS IN NEUROENDOCRINE CANCER. Patient and public involvement (PPI) in research is a very welcome and increasingly frequent requirement due to the potential benefits in the design of participant and researcher relevant,...
Have you heard our latest podcast episode?
In this latest episode of the Not Just NE Cancer podcast, Neuroendocrine Cancer UK CEO and Co-Founder, Cathy Bouvier Ellis sits down with Tanya Hills, Global Patient Engagement Lead at Boehringer Ingelheim. CLICK HERE to listen today!
